Table 1.
Characteristics of the study population undergoing CT-PG due to MBO associated with ovarian cancer.
| Histology | n = 31 |
|---|---|
| HGSOC | 22 (71%) |
| LGSOC | 5 (16%) |
| Mucinous | 3 (10%) |
| Clear cell | 1 (3%) |
| Status of disease | |
| Primary diagnosis | 4 (13%) |
| Recurrent disease | 27 (87%) |
| Platinum-resistant | 21 (68%) |
| Platinum-sensitive | 5 (16%) |
| Not assessable | 1 (3%) |
| Malignant ascites | |
| none | 10 (32%) |
| ≤500 mL | 13 (42%) |
| >500 mL | 8 (26%) |
| Prior lines of Chemotherapies | |
| none | 4 (13%) |
| 1–2 | 10 (32%) |
| ≥3 | 17 (55%) |
| Interventions for MBO prior to CT-PG insertion | |
| Attempt for PEG | 25 (81%) |
| Surgery for ileus | 3 (10%) |
| None | 4 (13%) |
| Chemotherapy after successful CT-PG | n = 25 |
| Platinum-based | 3 (12%) |
| Platinum-free | 4 (16%) |
| None | 18 (72%) |
| Procedure-related complications within 1 month | |
| Grade 4–5 | 0 |
| Grade 3 | 4 (16%) |
| Misplacement | 1 (4%) |
| Dislodgement | 2 (8%) |
| Leakage | 1 (4%) |
| Grade 1–2 | 6 (24%) |
| Local bleeding | 2 (8%) |
| Peristomal leakage | 1 (4%) |
| Local skin irritations | 4 (16%) |
HGSOC: High-grade serous ovarian cancer; LGSOC: Low-grade serous ovarian cancer; PEG: percutaneous endoscopic gastrostomy.